SAM
WVE icon

Smartleaf Asset Management’s Wave Life Sciences WVE Stock Holding History

Smartleaf Asset Management’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$14.9K Buy
2,252
+9
+0.4% +$117 ﹤0.01% 2118
2025
Q4 		$38.5K Buy
2,243
+1,942
+645% +$19.7K ﹤0.01% 1679
2025
Q3 		$2.15K Buy
+301
New +$2.44K ﹤0.01% 2599

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Smartleaf Asset Management's WVE Position: Q1 2026 in Review

Smartleaf Asset Management increased its Wave Life Sciences (WVE) stake by 0.4% in Q1 2026, buying an estimated $117 and bringing the position to 2,252 shares worth $14.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2118.

Smartleaf Asset Management first reported a position in WVE in Q3 2025 and has held it in 3 quarters since. The position peaked at $38.5K in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Smartleaf Asset Management held 2,252 shares of Wave Life Sciences worth $14.9K as of Q1 2026.
  • Smartleaf Asset Management bought 9 Wave Life Sciences shares in Q1 2026, an estimated $117.
  • Wave Life Sciences made up ﹤0.01% of Smartleaf Asset Management's portfolio in Q1 2026, its #2118 holding.
  • Smartleaf Asset Management first reported a position in Wave Life Sciences in Q3 2025 and has held it in 3 quarters since.
  • Smartleaf Asset Management's Wave Life Sciences position peaked at $38.5K in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Smartleaf Asset Management's 13F filing for Q1 2026, filed 15 May 2026.